Optimizing the aldosterone-to-renin ratio cut-off for screening primary aldosteronism based on cardiovascular risk: a collaborative study

Bibliographic Details
Title: Optimizing the aldosterone-to-renin ratio cut-off for screening primary aldosteronism based on cardiovascular risk: a collaborative study
Authors: Chunxue He, Ruolin Li, Jun Yang, Hang Shen, Yue Wang, Xiangjun Chen, Wenjin Luo, Qinglian Zeng, Linqiang Ma, Ying Song, Qingfeng Cheng, Zhihong Wang, Fei-Fei Wu, Qifu Li, Shumin Yang, Jinbo Hu
Source: Clinical and Experimental Hypertension, Vol 46, Iss 1 (2024)
Publisher Information: Taylor & Francis Group, 2024.
Publication Year: 2024
Collection: LCC:Diseases of the circulatory (Cardiovascular) system
Subject Terms: Aldosterone-to-renin ratio, cardiovascular risk, cutoff, primary aldsoteronism, screening, Diseases of the circulatory (Cardiovascular) system, RC666-701
More Details: Objectives Aldosterone-to-renin ratio (ARR) based screening is the first step in the diagnosis of primary aldosteronism (PA). However, the guideline-recommended ARR cutoff covers a wide range, from the equivalent of 1.3 to 4.9 ng·dl−1/mIU∙l−1. We aimed to optimize the ARR cutoff for PA screening based on the risk of cardiovascular diseases (CVD).Methods Longitudinally, we included hypertensive participants from the Framingham Offspring Study (FOS) who attended the sixth examination cycle and followed up until 2014. At baseline (1995–1998), we used circulating concentrations of aldosterone and renin to calculate ARR (unit: ng·dl−1/mIU∙l−1) among 1,433 subjects who were free of CVD. We used spline regression to calculate the ARR threshold based on the incident CVD. We used cross-sectional data from the Chongqing Primary Aldosteronism Study (CONPASS) to explore whether the ARR cutoff selected from FOS is applicable to PA screening.Results In FOS, CVD risk increased with an increasing ARR until a peak of ARR 1.0, followed by a plateau in CVD risk (hazard ratio 1.49, 95%CI 1.19–1.86). In CONPASS, when compared to essential hypertension with ARR
Document Type: article
File Description: electronic resource
Language: English
ISSN: 10641963
1525-6006
1064-1963
Relation: https://doaj.org/toc/1064-1963; https://doaj.org/toc/1525-6006
DOI: 10.1080/10641963.2023.2301571
Access URL: https://doaj.org/article/180268ee7dd145ed9c578a254007ea85
Accession Number: edsdoj.180268ee7dd145ed9c578a254007ea85
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:10641963
15256006
DOI:10.1080/10641963.2023.2301571
Published in:Clinical and Experimental Hypertension
Language:English